Stocks
ImmunoGen (IMGN) CAPEX/Revenue US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| CAPEX/Revenue, % | 9.75% | 3.46% | 0.69% | 1.25% | 1.25% | 0.38% | |||
| Changes by years, y/y, % | +9pp | -6pp | -3pp | +1pp | 0pp | +5.3% | |||
ImmunoGen. CAPEX/Revenue, %
ImmunoGen. CAPEX/Revenue, changes, pp
ImmunoGen (IMGN) CAPEX/Revenue US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q2 | 2023Q4 | 2024Q1 | 2023Q3 | LTM ? | |||
| CAPEX/Revenue, % | 0.18% | 0.09% | 0.09% | 0.00% | 1.19% | 0.38% | ||
| Changes by years, y/y, % | -4pp | -1pp | -1pp | 0pp | -3pp | |||
| Changes by quarters, q/q, % | 0pp | 0pp | 0pp | 0pp | ||||
